Home > Boards > US OTC > Biotechs > Amarantus Bioscience Holdings Inc. (AMBS)

$EMOR financial report 12. Subsequent Events. On 1/02/2020 - Emerald

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Ahjon81 Member Profile
 
Followed By 2
Posts 156
Boards Moderated 0
Alias Born 07/13/20
160x600 placeholder
Ahjon81   Wednesday, 12/16/20 10:02:51 PM
Re: None
Post # of 129758 
$EMOR financial report

12. Subsequent Events.
On 1/02/2020 - Emerald gained exclusive worldwide development rights from Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS), to ESS, MANF and PhenoGuard FDA regulated therapeutics with Amarantus to receive Emerald preferred stock valued at a minimum of $66.6 million.” 33M shares of $EMOR will be issued to $AMBS

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences